| BYND 1.18 1.72% | LOBO 0.7316 27.77% | ASBP 0.2361 -9.85% | CTNT 0.0442 -19.34% | FCHL 0.2595 15.33% | XRTX 2.84 26.22% | LOCL 2.7298 45.20% | EDBL 1.0245 11.36% | SOWG 0.156 -34.97% | TOVX 0.312 -23.90% | NVTS 16.17 22.50% | POET 10.41 21.19% | RPGL 0.7451 65.61% | SOXS 18.0295 -3.22% | HIMS 30.46 -1.77% | CLIK 3.6999 43.96% | INTC 66.94 1.89% | NVDA 201.5101 -0.27% | TSLL 13.17 -0.90% | PLUG 3.2 -0.62% | TQQQ 58.529 0.77% | BURU 0.2399 19.95% | BIYA 1.1926 37.06% | TZA 4.8901 -2.10% | SOUN 8.435 1.38% | LCID 7.625 12.96% | SLNH 1.4498 3.56% | OPEN 5.755 7.57% | BULL 7.205 2.78% | SOXL 99.08 3.27% | ONDS 11.1115 3.56% | LZMH 0.1181 -23.81% | NOK 10.585 -0.14% | SMR 12.53 -2.03% | SNAP 5.765 -3.92% | BITO 10.4399 -0.19% | SOFI 19.53 0.15% | SQQQ 56.48 -0.76% | PLTR 148.31 1.66% | SPRC 5.6701 34.04% | DVLT 0.7655 3.80% | NFLX 93.6601 -1.23% | FFAI 0.3297 15.00% | TSLA 390.81 -0.43% | AMZN 252.5026 1.70% | ALBT 0.3966 -19.03% | GPUS 0.1594 6.13% | HTZ 7.73 -1.02% | MRVL 153.17 3.61% | GNPX 1.1999 3.89%

Lazard Ltd (NYSE:LAZ) Earnings Preview and Financial Health Analysis

Lazard Ltd (NYSE:LAZ), a leading financial advisory and asset management firm, is gearing up to release its quarterly earnings on October 23, 2025. The firm, known for its expertise in mergers and acquisitions, restructuring, and capital raising, competes with financial giants such as Goldman Sachs and Morgan Stanley. Analysts are estimating an earnings per share (EPS) of $0.44 and revenue of $726.25 million. The consensus EPS estimate has seen a downward revision of 1.8% over the past 30 days, potentially impacting investor sentiment.

The market's reaction to earnings estimate revisions is significant, as empirical studies suggest. Should Lazard's actual earnings surpass expectations, the stock might witness an upward trend. On the other hand, if the earnings disappoint, the stock could face a decline. The insights shared during the earnings call will be crucial for investors to gauge the sustainability of any immediate price changes.

Examining Lazard's financial metrics reveals its market valuation. The firm boasts a price-to-earnings (P/E) ratio of 15.67, a price-to-sales ratio of 1.52, and an enterprise value to sales ratio of 1.37. These figures indicate how the market values Lazard's earnings and sales.

The company's financial health is underscored by a debt-to-equity ratio of 0.70 and a current ratio of 1.89. These ratios suggest a balanced approach to financing its assets and the ability to cover short-term liabilities with short-term assets, respectively. As Lazard approaches its earnings release, these metrics offer a comprehensive view of its financial standing.

Published on: October 23, 2025